Early and Mid-Term Results After Repair of Ischaemic Mitral Regurgitation with Complete Annuloplasty Ring and Incomplete Ring
Keywords:annuloplasty ring, flexible; ischaemic mitral regurgitation, mitral valve, repair, semi-rigid
Background: The choice of ring type for mitral valve (MV) repair is still debatable and usually is left to the surgeon's discretion.
Aim: The aim of this study was to compare the early and mid-term results after repair of ischaemic mitral regurgitation (MR) with complete and incomplete annuloplasty rings.
Methods: Collected data included preoperative assessment (age, sex, comorbidities, clinical status, NYHA grade, and the EURO score); intraoperative details (echocardiography, degree of MR, and cross-clamp time); and results (the length of ICU and hospital stay, duration and need for inotropes, duration of mechanical ventilation, and postoperative adverse events). Follow up after discharge included assessment of dyspnea status, the degree and progression of MR, and left ventricular function and dimensions.
Results: The present study included 133 patients: 61 with incomplete rings and 72 with complete rings inserted. There was no significant difference in the rate of postoperative complications between the two groups, apart from a significantly higher percentage of patients with incomplete ring who required prolonged ventilation >24 hours (P = 0.002). There were no significant differences between the two groups, regarding the grade of residual MR (P = 0.464), postoperative dyspnea status (P = 0.723), 30-day mortality rate (P = 0.687), and mean duration of survival (P = 0.276).
Conclusion: The choice of incomplete or complete annuloplasty ring was not associated with a marked difference in the early and midterm results of ischaemic MV repair.
Alame AJ, Karatasakis A, Karacsonyi J, Danek BA, Sorajja P, Gössl M, et al. 2017. Comparison of the American College of Cardiology/American Heart Association and the European Society of Cardiology Guidelines for the Management of Patients With Valvular Heart Disease. The Journal of Invasive Cardiology. 29(9):320-6.
Bursi F, Enriquez-Sarano M, Nkomo VT, Jacobsen SJ, Weston SA, Meverden RA, et al. 2005. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation. 111(3):295-301.
Carpentier AF, Lessana A, Relland JY, Belli E, Mihaileanu S, Berrebi AJ, et al. 1995. The "physio-ring": an advanced concept in mitral valve annuloplasty. Ann Thorac Surg. 60(5):1177-85; discussion 85-6.
Chee T, Haston R, Togo A, Raja SG. 2008. Is a flexible mitral annuloplasty ring superior to a semi-rigid or rigid ring in terms of improvement in symptoms and survival? Interactive Cardiovascular and Thoracic Surgery. 7(3):477-84.
Cosgrove DM, 3rd, Arcidi JM, Rodriguez L, Stewart WJ, Powell K, Thomas JD. 1995. Initial experience with the Cosgrove-Edwards Annuloplasty System. Ann Thorac Surg. 60(3):499-503; discussion -4.
David TE, Ivanov J, Armstrong S, Christie D, Rakowski H. 2005. A comparison of outcomes of mitral valve repair for degenerative disease with posterior, anterior, and bileaflet prolapse. The Journal of Thoracic and Cardiovascular Surgery. 130(5):1242-9.
De Bonis M, Taramasso M, Grimaldi A, Maisano F, Calabrese MC, Verzini A, et al. 2011. The GeoForm annuloplasty ring for the surgical treatment of functional mitral regurgitation in advanced dilated cardiomyopathy. European Journal of Cardiothoracic Surgery: official journal of the European Association for Cardio-thoracic Surgery. 40(2):488-95.
Dion R. 1993. Ischemic mitral regurgitation: when and how should it be corrected? The Journal of Heart Valve Disease. 2(5):536-43.
Dion R, Benetis R, Elias B, Guennaoui T, Raphael D, Van Dyck M, et al. 1995. Mitral valve procedures in ischemic regurgitation. The Journal of Heart Valve Disease. 4 Suppl 2:S124-9; discussion S9-31.
Fedak PW, McCarthy PM, Bonow RO. 2008. Evolving concepts and technologies in mitral valve repair. Circulation. 117(7):963-74.
Goldstein D, Moskowitz AJ, Gelijns AC, Ailawadi G, Parides MK, Perrault LP, et al. 2016. Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. N Engl J Med. 374(4):344-53.
Gorman JH, 3rd, Gorman RC, Jackson BM, Enomoto Y, St John-Sutton MG, Edmunds LH, Jr. 2003. Annuloplasty ring selection for chronic ischemic mitral regurgitation: lessons from the ovine model. Ann Thorac Surg. 76(5):1556-63.
Hu X, Zhao Q. 2011. Systematic evaluation of the flexible and rigid annuloplasty ring after mitral valve repair for mitral regurgitation. European Journal of Cardiothoracic Surgery: official journal of the European Association for Cardio-Thoracic Surgery. 2011;40(2):480-7.
Khamooshian A, Buijsrogge MP, de Heer F, Gründeman PF. 2014. Mitral valve annuloplasty rings: review of literature and comparison of functional outcome and ventricular dimensions. Innovations (Philadelphia, Pa). 9(6):399-415.
Kron IL, Hung J, Overbey JR, Bouchard D, Gelijns AC, Moskowitz AJ, et al. 2015. Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation. The Journal of Thoracic and Cardiovascular Surgery. 149(3):752-61.e1.
Kron IL, LaPar DJ, Acker MA, Adams DH, Ailawadi G, Bolling SF, et al. 2017. 2016 update to The American Association for Thoracic Surgery (AATS) consensus guidelines: Ischemic mitral valve regurgitation. The Journal of Thoracic and Cardiovascular Surgery. 153(5):e97-e114.
Michler RE, Smith PK, Parides MK, Ailawadi G, Thourani V, Moskowitz AJ, et al. 2016. Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation. N Engl J Med. 374(20):1932-41.
Onorati F, Rubino AS, Marturano D, Pasceri E, Mascaro G, Zinzi S, et al. 2009. Mid-term echocardiographic results with different rings following restrictive mitral annuloplasty for ischaemic cardiomiopathy. European Journal of Cardio-Thoracic Surgery: official journal of the European Association for Cardio-Thoracic Surgery. 36(2):250-60; discussion 60.
Otsuji Y, Levine RA, Takeuchi M, Sakata R, Tei C. 2008. Mechanism of ischemic mitral regurgitation. Journal of Cardiology. 51(3):145-56.
Pang PYK, Huang MJ, Tan TE, Lim SL, Naik MJ, Chao VTT, et al. 2019. Restrictive mitral valve annuloplasty for chronic ischaemic mitral regurgitation: outcomes of flexible versus semi-rigid rings. Journal of Thoracic Disease. 11(12):5096-106.
Pérez de Isla L, Zamorano J, Quezada M, Almería C, Rodrigo JL, Serra V, et al. 2007. Functional mitral regurgitation after a first non-ST-segment elevation acute coronary syndrome: contribution to congestive heart failure. Eur Heart J. 28(23):2866-72.
Saitto G, Lio A, Russo M, Nicolò F, Bassano C, Scafuri A, et al. 2018. Mitral Valve Repair with a Semi-Rigid C-Band Annuloplasty Ring in Ischemic Mitral Regurgitation: Still a Viable Surgical Option? The Journal of Heart Valve Disease. 27(1):47-54.
Silberman S, Klutstein MW, Sabag T, Oren A, Fink D, Merin O, et al. 2009. Repair of Ischemic Mitral Regurgitation: Comparison Between Flexible and Rigid Annuloplasty Rings. The Annals of Thoracic Surgery. 87(6):1721-7.
Suri RM, Schaff HV, Dearani JA, Sundt TM, 3rd, Daly RC, Mullany CJ, et al. 2006. Recurrent mitral regurgitation after repair: should the mitral valve be re-repaired? The Journal of Thoracic and Cardiovascular Surgery. 132(6):1390-7.
Rausch MK, Bothe W, Kvitting JP, Swanson JC, Miller DC, Kuhl E. 2012. Mitral valve annuloplasty: a quantitative clinical and mechanical comparison of different annuloplasty devices. Annals of Biomedical Engineering. 40(3):750-61.
Rossi A, Dini FL, Faggiano P, Agricola E, Cicoira M, Frattini S, et al. 2011. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart (British Cardiac Society). 97(20):1675-80.
Yokote J, Araki Y, Saito S, Hasegawa H, Usui A. 2019. Effect of an artificial ring on mitral valve function. Nagoya Journal of Medical Science. 81(2):207-15.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).